Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Juliusson

Showing results (81-90 of 114) with videos related to

Pageof 12
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 15, 1993
Chronic lymphocytic leukemia cells with allelic deletions at 13q14 commonly have one intact RB1 gene: evidence for a role of an adjacent locusY Liu, L Szekely, D Grandér, et al.
Blood|January 1, 1985
Prognostic information from cytogenetic analysis in chronic B-lymphocytic leukemia and leukemic immunocytomaG Juliusson, K H Robèrt, A Ost, et al.
Leukemia & Lymphoma|July 28, 2016
Cytogenetic Findings and Survival in B-cell Chronic Lymphocytic Leukemia. Second IWCCLL Compilation of Data on 662 PatientsG Juliusson, D Oscier, G Juliusson, et al.
Lancet (London, England)|May 25, 1996
Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLLS Johnson, A G Smith, H Löffler, et al.
Blood|April 1, 1996
Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non-Hodgkin's lymphoma--a randomized multicenter study. The European Study Group of Erythropoietin (Epoetin Beta) Treatment in Multiple Myeloma and Non-Hodgkin's LymphomaA Osterborg, M A Boogaerts, R Cimino, et al.
European Journal of Haematology|July 1, 1989
Alternating combination chemotherapy (VMCP/VBAP) is not superior to melphalan/prednisone in the treatment of multiple myeloma patients stage III--a randomized study from MGCSA Osterborg, A Ahre, M Björkholm, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Chlorambucil/prednisone vs. CHOP in symptomatic low-grade non-Hodgkin's lymphomas: a randomized trial from the Lymphoma Group of Central SwedenE Kimby, M Björkholm, G Gahrton, et al.
British Journal of Haematology|October 1, 1991
Treatment of multiple myeloma with interferon alpha: the Scandinavian experienceH Mellstedt, A Osterborg, M Björkholm, et al.
European Journal of Haematology|August 1, 1988
High doses of natural alpha-interferon (alpha-IFN) in the treatment of multiple myeloma--a pilot study from the Myeloma Group of Central Sweden (MGCS)A Ahre, M Björkholm, A Osterborg, et al.
European Journal of Haematology|July 1, 1995
Mitoxantrone, etoposide and ara-C vs doxorubicin-DNA, ara-C, thioguanine, vincristine and prednisolone in the treatment of patients with acute myelocytic leukaemia. A randomized comparisonM Björkholm, J Liliemark, G Gahrton, et al.
Pageof 12

Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
Proceedings of the National Academy of Sciences of the United States of America|September 15, 1993
Chronic lymphocytic leukemia cells with allelic deletions at 13q14 commonly have one intact RB1 gene: evidence for a role of an adjacent locusY Liu, L Szekely, D Grandér, et al.
Blood|January 1, 1985
Prognostic information from cytogenetic analysis in chronic B-lymphocytic leukemia and leukemic immunocytomaG Juliusson, K H Robèrt, A Ost, et al.
Leukemia & Lymphoma|July 28, 2016
Cytogenetic Findings and Survival in B-cell Chronic Lymphocytic Leukemia. Second IWCCLL Compilation of Data on 662 PatientsG Juliusson, D Oscier, G Juliusson, et al.
Lancet (London, England)|May 25, 1996
Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLLS Johnson, A G Smith, H Löffler, et al.
Blood|April 1, 1996
Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non-Hodgkin's lymphoma--a randomized multicenter study. The European Study Group of Erythropoietin (Epoetin Beta) Treatment in Multiple Myeloma and Non-Hodgkin's LymphomaA Osterborg, M A Boogaerts, R Cimino, et al.
European Journal of Haematology|July 1, 1989
Alternating combination chemotherapy (VMCP/VBAP) is not superior to melphalan/prednisone in the treatment of multiple myeloma patients stage III--a randomized study from MGCSA Osterborg, A Ahre, M Björkholm, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Chlorambucil/prednisone vs. CHOP in symptomatic low-grade non-Hodgkin's lymphomas: a randomized trial from the Lymphoma Group of Central SwedenE Kimby, M Björkholm, G Gahrton, et al.
British Journal of Haematology|October 1, 1991
Treatment of multiple myeloma with interferon alpha: the Scandinavian experienceH Mellstedt, A Osterborg, M Björkholm, et al.
European Journal of Haematology|August 1, 1988
High doses of natural alpha-interferon (alpha-IFN) in the treatment of multiple myeloma--a pilot study from the Myeloma Group of Central Sweden (MGCS)A Ahre, M Björkholm, A Osterborg, et al.
European Journal of Haematology|July 1, 1995
Mitoxantrone, etoposide and ara-C vs doxorubicin-DNA, ara-C, thioguanine, vincristine and prednisolone in the treatment of patients with acute myelocytic leukaemia. A randomized comparisonM Björkholm, J Liliemark, G Gahrton, et al.
Pageof 12